Click image to view original image
PharmaLegacyCell line-Derived Xenograft (CDX model) is a well-established and commonly used mouse tumor model type for the research and development of anti-tumor drugs and immunotherapy. More recently, human tumors implanted directly into immunodeficient mice have become increasingly popular as evidence accrues that they more accurately recapitulate features of patient tumors. However, CDX model still possesses pervasive application at the early stage of in vivo study, due to its user-friendly techniques as well as excellent repeatability.With decades of operational experience and technology platform of tumor cells, Pharmalegacy has established various well-validated cell-line-derived xenograft (CDX model) to satisfy your in vivo research, of which both solid tumors and precious hematological malignances models are available to customers. Our all-around products involve CDX model construction and delivery, in vivo projects execution as well as the final results presentation in the field of oncology research.is focused on Most advanced CDX Model, Integrity CDX Model, Excellent CDX Model, A good brand CDX Model and other projects. even though in the rapid development of the project ,PharmaLegacy always stressed the balance between external opportunities and internal management, attaches great importance to the core competitiveness of enterprises to cultivate and shape. Our company take the value of customer service as the core competitiveness of enterprises, adhering to the honesty and integrity , the pursuit of excellence, respect individual for the corporate spirit, and strive to provide customers with integrity and reliable CDX Model.
